Amanote Research

Amanote Research

    RegisterSign In

JAK2 Inhibitors: Are They the Solution?

Clinical Lymphoma, Myeloma and Leukemia - United States
doi 10.1016/j.clml.2011.02.007
Full Text
Open PDF
Abstract

Available in full text

Categories
Cancer ResearchOncologyHematology
Date

June 1, 2011

Authors
Fabio P.S. SantosSrdan Verstovsek
Publisher

Elsevier BV


Related search

SGLT-2 Inhibitors – Are They to Stay?

Diabesity
2017English

Therapeutic Potential of JAK2 Inhibitors

The Journal of OncoPathology
2013English

Electric Cars - Are They Solution to Reduce CO2 Emission?

Thermal Science
Renewable Energythe EnvironmentSustainability
2020English

Revisiting Early Postinjury Mortality: Are They Bleeding Because They Are Dying or Dying Because They Are Bleeding?

Journal of Surgical Research
Surgery
2013English

They Are From the Government and They Really Are Here to Help You

Journal of Clinical Pharmacology
Pharmacology
2008English

The Times They Are A-Changin'

Blood
BiochemistryImmunologyCell BiologyHematology
2011English

Time Domain Structures: What and Where They Are, What They Do, and How They Are Made

Geophysical Research Letters
EarthPlanetary SciencesGeophysics
2015English

Trade Wars: What Do They Mean? Why Are They Happening Now? What Are the Costs?

Policy Research Working Papers
2019English

The Times They Are a Changing…

Journal of Aquatic Food Product Technology
Aquatic ScienceFood Science
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy